Top 10 pharmaceutical companies based on global vaccine revenue market share in 2017 and 2024

Leading pharmaceutical companies and total global vaccine market share 2017 and 2024 This statistic displays the top 10 global pharmaceutical companies based on their vaccine revenue market share worldwide in 2017, and a projection for 2024. Pfizer is expected to account for some 16 percent of the global vaccine market by 2024, largely due to success with its pneumococcal vaccine, Prevnar 13. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
Show more
Loading statistic...
Expand statistic
20172024*
GlaxoSmithKline24%24.1%
Merck & Co.23.6%21.1%
Sanofi20.8%18.2%
Pfizer21.7%16.3%
Novavax-5.9%
Emergent BioSolutions1%2.5%
CSL3%2.4%
Inovio Pharmaceuticals-1.5%
Bavarian Nordic0%1.2%
Mitsubishi Tanabe1.5%1.1%
20172024*
GlaxoSmithKline24%24.1%
Merck & Co.23.6%21.1%
Sanofi20.8%18.2%
Pfizer21.7%16.3%
Novavax-5.9%
Emergent BioSolutions1%2.5%
CSL3%2.4%
Inovio Pharmaceuticals-1.5%
Bavarian Nordic0%1.2%
Mitsubishi Tanabe1.5%1.1%
Download Settings Share
Chart type
Datalabels
Share on Social Media
HTML code to embed chart as PNG (FAQ)
Download started
Please be patient - this may take a moment
Description Source More information
This statistic displays the top 10 global pharmaceutical companies based on their vaccine revenue market share worldwide in 2017, and a projection for 2024. Pfizer is expected to account for some 16 percent of the global vaccine market by 2024, largely due to success with its pneumococcal vaccine, Prevnar 13. A vaccine often contains an agent that is made from a weakened form of a disease microbe, that is then used to stimulate the body's immune system to destroy and recognize the microorganism in case of later exposures.
Show more
Release date
June 2018
Region
Worldwide
Survey time period
as of May 2018
Supplementary notes
* Projected.

More information

Statista Accounts: Access All Statistics. Starting from $588 / Year

Basic Account

Get to know the platform

You only have access to basic statistics.

Register for free

Premium Account

Your perfect start with Statista

  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account

Full access

Corporate solution including all features.

Send request

* All products require an annual contract.
   Prices do not include sales tax
   (New York residents only).
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom

Related Studies: Available to Download in PDF or PPTX Format

Merck & Co.
Merck & Co.

All Information
in one Presentation

Merck & Co.

Everything On "Merck & Co." in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Merck & Co."

  • Global positioning
The most important statistics
  • Overview
  • Revenues
  • Expenses
  • Shares/stockholders
Need help with using Statista for your research? Tutorials and first steps

Further Content: Statistics, Studies, and Topic Pages

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.

News
News